Marie Luksch, DO
Gynecology · Paoli, PANPI 1801183413
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations.
Across 101 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$357
- Therapeuticsmd, Inc.$262
- Sage Therapeutics, LLC$109
- Mayne Pharma Commercial LLC$102
- Myovant Sciences Inc.$86
- Conmed Corporation$82
- plus $798 from 22 others
What the payments were for
- Food & beverage$1,78299%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $357 |
| Therapeuticsmd, Inc. | 17 | $262 |
| Sage Therapeutics, LLC | 6 | $109 |
| Mayne Pharma Commercial LLC | 8 | $102 |
| Myovant Sciences Inc. | 5 | $86 |
| Conmed Corporation | 1 | $82 |
| Daiichi Sankyo Inc. | 4 | $70 |
| Smith+Nephew | 4 | $70 |
| Pfizer | 4 | $69 |
| Sumitomo Pharma America, Inc. | 3 | $54 |
| Millicent US Inc | 3 | $48 |
| Shield Therapeutics Inc | 1 | $47 |
| Astellas Pharma US Inc | 2 | $43 |
| Dysis Medical, Inc. | 1 | $42 |
| Coopersurgical, Inc. | 2 | $41 |
| Baxter Healthcare | 1 | $41 |
| Bayer | 2 | $40 |
| Duchesnay USA Incorporated | 2 | $35 |
| Exeltis, USA Inc. | 2 | $32 |
| Organon | 2 | $25 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Convatec Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Mission Pharmacal Company | 1 | $18 |
| Vertex | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $12 |
How this compares
$1,796 in reported general payments places this provider in the 70th percentile of 98 gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 17 | $924 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Paoli
- Jordan KlebanoffNewtown Square$187K
- Harry ReichShavertown$136K
- Gretchen MakaiYork$102K
- Karen TangBryn Mawr$96K
- Joseph TalvacchiaPhiladelphia$85K
- David ToubWyncote$41K
- David EvansCarlisle$30K
- Harold DavisScranton$22K
- Reneita RossPhiladelphia$8K
- Marydonna RavasioButler$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.